Key statistics
As of last trade ONWARD Medical NV (63E:FRA) traded at 4.94, -24.46% below its 52-week high of 6.54, set on Mar 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.94 |
---|---|
High | 4.94 |
Low | 4.92 |
Bid | 4.88 |
Offer | 5.48 |
Previous close | 4.96 |
Average volume | 0.00 |
---|---|
Shares outstanding | 34.63m |
Free float | 32.52m |
P/E (TTM) | -- |
Market cap | 180.07m EUR |
EPS (TTM) | -1.09 EUR |
Data delayed at least 15 minutes, as of Oct 08 2024 08:59 BST.
More ▼
Announcements
- ONWARD® Medical Annonce la Cotation de ses Titres sur le Marché Euronext Paris
- ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury
- ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine (BCI) pour restaurer le mouvement après une lésion de la moelle épinière
- ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update
- ONWARD® Medical and Partners Awarded Christopher & Dana Reeve Foundation Grant to Further Study Brain-Computer Interface System
- ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
- ONWARD® Medical Reaffirms 2024 Strategic Priorities and Releases Unaudited Q2 Financial Highlights
- ONWARD® Medical Publishes Annual Sustainability Summary
- ONWARD® Medical Announces Publication Highlighting Evidence-based Programming for ARC-EX® Therapy
- ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC
More ▼